Global Vocal Biomarkers Market to Exhibit a Healthy Growth in 2019, Asserts MRFR
Global vocal biomarkers market to witness a healthy growth in forthcoming years projects Market Research Future (MRFR) in its latest report. Increased prevalence of neurological, psychological and other disorders that affects speech is fuelling the demand for vocal biomarkers. Health issues such as Disruptive Behavior Disorders, Alzheimer's disease, Parkinson's disease (PD), Huntington's disease, attention deficit, depression, and respiratory and cardiovascular disorders are associated with speech impairment. There are cases when traumatic brain injury (TBI) was identified as cause of speech loss. A WHO report revealed that in 2016, close to 350 million people were suffering from depression. In the same, The Parkinson’s disease Foundation reported that around 10 million people were suffering Parkinson’s.
Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/3933
Biomarkers are also used for detecting speech related issues in soldiers. Hence, the defence sector has potential for vocal biomarker application. For instance, the U.S Army joined forces with MIT researcher to collaboratively work on developing advanced biomarker technology that can cater to traumatic brain injury. America Heart Association in partnership with Mayo Clinic and Beyond Verbal has created unique artificial intelligence (AI) algorithms using cutting-edge machine-learning tools to perceive voice patterns uncatchable by human ear for initial identification of coronary heart disorders.
Rapid mobile technology penetration and boom of the IT sector is creating supporting the market growth. Moreover, the arrival of advanced wearable technologies along with improving the network quality and bandwidth is partly influencing the market. Market players are actively focusing on product innovation in order to gain a competitive edge. Many companies are also entering into collaboration and partnerships to boost their R&D capacity.
Segmental Overview
The segmental analysis of the global vocal biomarker market is based on indication, type and end users.
On the basis of indication, the market has been segmented into neurological disorders, psychiatric disorders, respiratory disorders, traumatic brain injury (TBI), cardiovascular disorder. The neurological disorders segment is further sub-segmented into Alzheimer’s disease, Parkinson’s disease, huntington’s disease, and others. The psychiatric disorders segment is further sub-segmented into disruptive behaviour disorders, attention deficit, depression and others. On the basis of type, the market has been segmented into pitch, amplitude, vocal rise or fall time, voice tremor, frequency, error rate, phonation time, and others. On the basis of end users, the market has been segmented into academic and research, hospitals and clinics and others.
Global Vocal Biomarkers Market: Regional Segmentation
The market has been covered across key regions, which include North America, Asia Pacific (APAC), Europe, the Middle East & Africa (MEA) and Latin America. North America is expected to remain highly profitable market for vocal biomarkers during the forecast period. In North America, the U.S. makes a significant contribution to the vocal biomarker market. This is primarily owing to the presence of effective reimbursement scenario and high healthcare spending. Moreover, faster acceptance of the advanced technologies in the U.S. makes it a potential market. Following on the heels of North America, Europe represents the second largest market for vocal biomarker. High level of awareness and growing healthcare expenditure are two of the key factors driving the market in Europe. Asia-Pacific ranks third in the pecking order in terms revenue. The market in APAC is touted to witness a strong growth over the next several years. India and China are major contributors to the market in the region.
Competitive Landscape
MRFR in its report has mentioned some of leading companies operating in the global vocal biomarker market, which include Sonde Health, IBM Corporation, Beyond Verbal, Cogito Corporation, and Audio Profiling.
Read More @ https://www.marketresearchfuture.com/reports/vocal-biomarkers-market-3933
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: [email protected]
NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
Market HighlightsThe vocal biomarkers market is chiefly driven by rise in cases of psychological, neurological and other diseases affecting speech such as depression, Attention Deficit and Disruptive Behavior Disorders, Parkinson's disease (PD), Alzheimer's disease, Huntington's disease, Respiratory and Cardiovascular Disorders, traumatic brain injury (TBI) etc.
According to WHO estimates, around 350 million individuals were suffering from depression in 2016 while the Parkinson’s disease Foundation, estimated about 10 million individuals Parkinson’s patients globally in 2016.
Thus, growing global disease prevalence will drive vocal biomarkers market size in the coming years.
Another potential area of application is the use of voice biomarkers to detect disorders in employees and soldiers.
For example, the U.S. Army entered collaboration with MIT researchers to develop voice biomarkers technology for traumatic brain injury.
American Heart Association in collaboration with Beyond Verbal and Mayo Clinic has developed artificial intelligence (AI) algorithms by using machine-learning to perceive voice patterns imperceptible to human ear for initial identification of coronary heart disease.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/3933The increasing penetration of mobile technology and information technology is driving the market.
Vocal Biomarkers Market information: by type (frequency, amplitude, error rate, vocal rise or fall time, phonation time, voice tremor, pitch, others) by indications (psychiatric disorders (depression, Attention Deficit and Disruptive Behavior Disorders, others), neurological disorders (Parkinson's disease (PD), Alzheimer's disease, Huntington's disease, others), Respiratory Disorders, Cardiovascular Disorders, traumatic brain injury (TBI), others), others) by end users (hospitals and clinics, academic and research, others) - Global Forecast till 2027Market HighlightsThe vocal biomarkers market is chiefly driven by rise in cases of psychological, neurological and other diseases affecting speech such as depression, Attention Deficit and Disruptive Behavior Disorders, Parkinson's disease (PD), Alzheimer's disease, Huntington's disease, Respiratory and Cardiovascular Disorders, traumatic brain injury (TBI) etc.
Thus growing global disease prevalence will drive vocal biomarkers market size in the coming years.
Another potential area of application is the use of voice biomarkers to detect disorders in employees and soldiers.
For example, the U.S. Army entered into collaboration with MIT researchers to develop voice biomarkers technology for traumatic brain injury.
American Heart Association in collaboration with Beyond Verbal and Mayo Clinic has developed artificial intelligence (AI) algorithms by using machine-learning to perceive voice patterns imperceptible to human ear for initial identification of coronary heart disease.Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/3933The increasing penetration of mobile technology and information technology is driving the market.
Product development is an important strategy and the increasing collaboration between technology companies and research institutes will yield multiple benefits to both partners.
